Trop-2 ADC (investigational)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Trop-2 ADC (investigational), covering 2025-03-25 to 2025-03-25. Get the full timeline:
Most recent: Clinical Trial Update: A Multicenter, Prospective, Cohort Study of Trop-2 ADC Combination Therapy for Advanced Triple-negative Breast Cancer [Phase 2]